As Americans celebrate National Colorectal Cancer Awareness Month (March), the Colon Cancer Alliance, Colontown — a survivor/patient support group for colorectal disease, including cancer — and the American College of Radiology (ACR) call on Congress to pass the Computed Tomography (CT) Colonography Screening for Colorectal Cancer Act (H.R. 991). Introduced recently by Reps. Ralph Hall (TX-04) and Danny Davis (D-IL), H.R. 991 would require Medicare to cover beneficiaries for CT colonography — otherwise known as virtual colonoscopy.
Fujifilm SonoSite Inc. announced the launch of AxoTrack Needle Guidance Technology on select SonoSite Ultrasound Systems. This newly developed product, named by Popular Science Magazine as one of 2012’s best new innovations, is now available for use with SonoSite M-Turbo Ultrasound Systems.
The American College of Radiology (ACR) has affirmed its support for the Diagnostic Imaging Services Access Protection Act (S. 623) recently introduced in the Senate by Senators Ben Cardin (D-MD) and David Vitter (R-LA).
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
Piramal Imaging SA, a division of Piramal Enterprises, announced that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted its applications for review of the investigational positron emission tomography (PET) amyloid imaging agent [18F] florbetaben. A New Drug Application (NDA) was submitted to the FDA and a Marketing Authorization Application to the EMA for [18F] florbetaben use in the visual detection of beta-amyloid in the brains of adults with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive decline. [18F] florbetaben binds to beta-amyloid plaques in the human brain, a hallmark characteristic in Alzheimer's disease.
FujiFilm Medical Systems U.S.A. Inc. showcased its Synapse 3D at the American College of Cardiology (ACC) conference March 9 to 11, 2013 at the Moscone Center in San Francisco, Calif. Fully integrated with Synapse Cardiovascular, Synapse 3D will appeal to cardiologists and cardiovascular specialists interested in advanced visualization and analysis for their diagnostic needs.

SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) launched a new online resource for imaging professionals, referring physicians and the public on dose optimization for nuclear medicine and molecular imaging procedures.
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
TeraMedica announced a Partner Agreement with Frontier Solutions Group. FrontierSG now offers complete VNA solutions including integrated storage products from IBM and TeraMedica’s Evercore Clinical Enterprise Suite, the leading vendor neutral archive (VNA) in the industry.
The American Society of Echocardiography (ASE) released a list of five interventions whose appropriateness physicians and patients should discuss as part of Choosing Wisely, an initiative of the ABIM Foundation, along with Consumer Reports. Third in the list, they ask that patients and their doctors talk about the real need for an echocardiogram when preparing for a surgery.
For many patients, diagnosing their back, hip or knee pain is best accomplished by imaging anatomy in a weight-bearing, or standing, position. At the 2013 Annual Meeting of the American Academy of Orthopedic Surgeons in Chicago, Esaote introduces the new G-scan Brio with eXP technology to give physicians a cost-effective tool for performing both traditional and weight-bearing musculoskeletal magnetic resonance imaging (MRI) exams.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
The LumaGEM Molecular Breast Imaging (MBI) business of Gamma Medica Inc. has been acquired through a chapter 11 sale by Imaging Acquisition Inc., an entity controlled by healthcare growth equity firm Psilos Group Managers LLC. Molecular breast imaging is an adjunct technology to mammography which radiologists use to help diagnose cancerous lesions in women with dense breast tissue. Already used in 15 prestigious medical institutions and clinical practices throughout the United States, the acquisition and investment by Psilos will enable the more focused company to meet the rapidly growing demand for LumaGEM.
McKesson highlighted enhancements to its cardiovascular information system (CVIS) version 13. The system offers new ...
Only one radiological modality – mammography – is used today for screening. Yet, as America hurdles toward preventive medicine, screening is where it will be at. Now researchers in Cleveland are floating the idea of using MRI as a standard procedure in annual checkups.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Virginia has amended its breast density inform law to include language in information given to patients explaining the risk of dense breast tissue. Originally signed into law by Gov. Bob McDonnell in 2012, the amendment strengthens the density notification to women and is modeled after laws in New York and California. The amendment to the law becomes effective July 1, 2013.
The Medical Imaging and Technology Alliance (MITA), Advanced Medical Technology Association (AdvaMed) and the Medical Device Manufacturers Association (MDMA) applauded the adoption of an amendment to the Fiscal Year 2014 Senate Budget Resolution that expresses support for repeal of the medical device tax.
A new report that breast cancer patients treated with low doses of radiation therapy have a heightened risk of heart disease suggests that physicians need to work with patients before, during, and after treatment to minimize that risk, according to an accompanying editorial in the March 14 issue of the New England Journal of Medicine.
GE Healthcare announced the U.S. Food and Drug Administration (FDA) approval of a new indication for AdreView (Iobenguane I 123 Injection), the first and only FDA approved molecular imaging agent to link nerve function in the heart to a patient’s mortality risk.[1] AdreView is approved for the scintigraphic assessment of myocardial sympathetic innervation (cardiac nerve activity) to assist in the evaluation of patients with New York Heart Association (NYHA) Class II or Class III heart failure and left ventricular ejection fraction (LVEF) ? 35 percent.[2]
Network security issues, vital infrastructure upgrades, electronic health record (EHR) implementation and impending federal deadlines will guide priorities this year, according to an independent research study of 100 healthcare provider CIOs and senior IT executives that was commissioned by Level 3 Communications Inc.
Carestream was awarded 43 patents from the U.S. Patent and Trademark Office in 2012 for innovations in radiology imaging, healthcare IT, dental imaging and other areas, capping another strong year for technology development across its businesses. These new patents include: improvements in digital radiography detectors; advanced image processing techniques for digital radiography, mammography exams and specialty applications; and medical imaging advancements for use in intensive care units, orthopedics and mobile X-ray systems.
Merge Healthcare Incorporated featured its iConnect Clinical Enterprise Platform at the HIMSS13 Interoperability Showcase and in Merge's booth at this year's HIMSS conference in New Orleans.
Guerbet announced that the U.S. Food and Drug Administration (FDA) has approved Dotarem (gadoterate meglumine), a gadolinium-based contrast agent (GBCA) indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues in adult and pediatric patients (2 years of age and older) to detect and visualize areas with disruption of the blood brain barrier (BBB) and/or abnormal vascularity.